ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's other long-term assets for the quarter that ended in Sep. 2014 was $151 Mil.
Alexion Pharmaceuticals Inc's quarterly other long-term assets increased from Mar. 2014 ($59 Mil) to Jun. 2014 ($85 Mil) and increased from Jun. 2014 ($85 Mil) to Sep. 2014 ($151 Mil).
Alexion Pharmaceuticals Inc's annual other long-term assets declined from Dec. 2011 ($116 Mil) to Dec. 2012 ($52 Mil) but then increased from Dec. 2012 ($52 Mil) to Dec. 2013 ($66 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Alexion Pharmaceuticals Inc Annual Data
|Other Long-Term Assets||12||15||38||5||8||200||159||116||52||66|
Alexion Pharmaceuticals Inc Quarterly Data
|Other Long-Term Assets||86||28||52||72||66||55||66||59||85||151|